The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional) |
93.242, 93.273, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.865 |
RFA-AI-19-022 |
| Medical Rehabilitation Research Resource (P2C Clinical Trial Optional) |
93.173, 93.213, 93.286, 93.361, 93.853, 93.865 |
RFA-HD-20-004 |
| Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-19-002 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-19-004 |
| Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) |
93.393, 93.394, 93.395 |
RFA-CA-19-034 |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) |
93.350, 93.853 |
PAR-19-220 |
| Maximizing Access to Research Careers (T34) |
93.859 |
PAR-19-219 |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) |
93.859 |
PAR-19-218 |
| Administrative Supplement for Research on Bioethical Issues |
93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.865, 93.866, 93.989 |
PA-19-217 |
| Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed) |
93.837, 93.838, 93.840 |
RFA-HL-20-004 |
| BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial |
93.839, 93.840 |
RFA-HL-20-009 |
| BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center |
93.839, 93.840 |
RFA-HL-20-010 |
| Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-19-010 |
| Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-006 |
| Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional) |
93.837, 93.838, 93.840 |
RFA-HL-20-003 |
| Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) |
93.286 |
PAR-19-215 |
| Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-19-501 |
| Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
93.242 |
PAR-19-214 |
| Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
93.273, 93.279 |
PAR-19-213 |
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
93.273, 93.279 |
PAR-19-212 |
| Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
PAS-19-210 |
| Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed) |
93.853, 93.866 |
RFA-NS-19-015 |
| NINDS Institutional Research Training Program (T32) |
93.853 |
PAR-19-211 |
| Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-028 |
| Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-19-029 |
| Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-014 |
| Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-20-013 |
| Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
93.855 |
PAR-19-209 |
| Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) |
93.273, 93.279 |
PAR-19-207 |
| Limited Competition: NIGMS Legacy Community-Wide Scientific Resources (R24 Clinical Trial Not Allowed) |
93.859 |
PAR-19-208 |
| Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-19-205 |
| Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-030 |
| Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-19-031 |
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Not Allowed) |
93.867 |
PAR-19-203 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) |
93.121, 93.213, 93.233, 93.273, 93.279, 93.313, 93.361, 93.393, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866 |
PA-19-200 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) |
93.121, 93.213, 93.273, 93.279, 93.313, 93.361, 93.393, 93.853, 93.866 |
PA-19-201 |
| Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) |
93.172, 93.242 |
PAR-19-204 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-19-199 |
| High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) |
93.847 |
PAR-19-202 |
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) |
93.393, 93.396 |
PAR-19-198 |
Search Results 3601-3640 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
